| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/27/2002 | CA2430595A1 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side-effect |
| 06/26/2002 | EP1216699A1 Transdermal system comprising a highly potent progestin |
| 06/26/2002 | EP1216221A2 Rxr modulators with improved pharmacologic profile |
| 06/26/2002 | EP1216050A2 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/26/2002 | CN1355842A Methods for making proteins containing free cysteine residues |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1086700C Benzothiophene compounds, intermediates, composition, and methods |
| 06/25/2002 | US6410743 (1s,2s)-2-(2-(n-((3-benzoimidazol-2-yl)propyl)-n-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048171A1 Methylene steroids as novel androgens |
| 06/20/2002 | WO2002048169A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002047714A1 Management of the consequences of fetal programming |
| 06/20/2002 | WO2002047702A1 Compositions for inducing secretion of insulin-like growth factor-1 |
| 06/20/2002 | WO2002047693A2 Steroid hormone products comprising a stabilizing agent in non-crystalline form |
| 06/20/2002 | WO2002047692A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 06/20/2002 | WO2001089570A3 Combination of growth hormone secretagogues and antidepressants |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001068068A3 Compounds capable of binding with the cytoskeleton |
| 06/20/2002 | WO2001056590A3 Utilization of protein kinase inhibitor alpha |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | US20020077461 Pharmaceutical formulation |
| 06/20/2002 | US20020077364 Thyroid hormone formulations |
| 06/20/2002 | US20020077360 Administering to a mammal a retinoid campound which binds specifically or selectively to a RAR alpha retinoid receptors in preference over RAR beta and RAR Gamma retinoid receptors, for therapy and prophylaxisof disease or condition |
| 06/20/2002 | US20020077356 Nonsteroidal antiinflammatory agents |
| 06/20/2002 | US20020077351 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation |
| 06/20/2002 | US20020077340 Pyridone inhibitors of fatty acid binding protein and method |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077320 For use as hypolipidemic, antihyperglycemic compounds |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | US20020076781 Regulation of intracellular glucocorticoid concentrations |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | CA2431328A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214348A2 Parathyroid hormone analogues for the treatment of osteoporosis |
| 06/19/2002 | EP1214347A2 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214313A2 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214086A2 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 06/19/2002 | EP1214076A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 06/19/2002 | EP1056769B1 15-methyl-cyclopropanosteroids and method for the production thereof |
| 06/18/2002 | US6407127 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity |
| 06/18/2002 | US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 06/18/2002 | US6407101 Progesterone receptor antagonists; contraceptives, hormone replacement therapy; breast and prostate cancer treatment; menopause |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA2356812A1 Tnf-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/18/2002 | CA2241725C Growth-hormone secretagogues |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046424A2 Fibroblast growth factors |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2002045712A1 Novel method and use |
| 06/13/2002 | WO2002029010A3 Method for obtaining in vitro mammal islet cells and uses thereof |
| 06/13/2002 | WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 06/13/2002 | WO2001094415A3 Nuclear hormone receptor |
| 06/13/2002 | WO2001074844A3 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 06/13/2002 | WO2001074839A3 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 06/13/2002 | WO2001068828A3 Compositions and methods for regulated protein expression in gut |
| 06/13/2002 | US20020072631 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 06/13/2002 | US20020072630 Therapy |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/13/2002 | CA2678490A1 Isolated placental perfusate and placental cells isolated therefrom |
| 06/13/2002 | CA2436601A1 Perturbed membrane-binding compounds |
| 06/13/2002 | CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | CA2431374A1 Novel fibroblast growth factors |
| 06/13/2002 | CA2431203A1 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | CA2430989A1 Method of collecting placental stem cells |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430376A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/12/2002 | EP1212421A1 Gas1 polypeptides |
| 06/12/2002 | EP1212363A2 Il-16 antagonists |
| 06/12/2002 | EP1212351A1 Method for producing cyclic peptidomimetics |
| 06/12/2002 | EP1212346A1 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP1212345A2 Orally active 7.alpha.-alkyl androgens |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212335A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 06/12/2002 | EP1212330A1 Androgen receptor modulator compounds and methods |